The Georgetown Lombardi Comprehensive Cancer Center was founded in 1970 and includes a partnership with Georgetown University Medical Center and Georgetown University Hospital. Due to its focus on patient care, basic and clinical research, prevention, education, outreach and training, the Georgetown Lombardi Comprehensive Cancer Center is designated as a Comprehensive Cancer Center by the National Cancer Institute and is the only NCI designated Comprehensive Cancer Center in Washington, DC.
Lombardi Comprehensive Cancer Center runs several specialized programs with its more than $100 million in research grant dollars. These programs are the Breast Cancer Research Program, Cancer Prevention and Control Program, Experimental Therapeutics Program, and the Drug Discovery Program.
Lombardi Comprehensive Cancer Center is listed as one of the top 50 cancer hospitals by the US News and World Report.
The Georgetown Lombardi Comprehensive Cancer Center is situated to provide the latest research developments to provide improved cancer treatment options. The integrated research environment provides collaboration of laboratory scientists and physicians within clinical, translational, and prevention research studies.
Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state of the art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, and comprehensive and preventive care are all options in the Georgetown Lombardi Comprehensive Cancer Center’s cancer treatment program.